tirzepatide and ckd Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial

Tirzepatide (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https

20.85

★★★★☆4.8 (126)

Can tirzepatide (Zepbound) be used in a patient with chronic kidney disease and an estimated glomerular filtration rate of 28 mL/min/1.73 m², and what dosing and monitoring recommendations are appropriate?

21.13

★★★★★4.9 (98)

SURPASS-4: Tirzepatide slows kidney disease in adults with type 2 diabetes, CV risk

27.30

★★★★★5.0 (157)

Can tirzepatide be used to treat an obese patient with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM), and what is the recommended dose?

27.65

★★★★★4.7 (84)

Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes

21.69

★★★★★4.9 (203)

Weight Loss Injections for Chronic Kidney Disease Patients: A UK Clinical Guide (2026)

23.36

★★★★★5.0 (176)

Tirzepatide Prescribing Practices and Efficacy in Patients with Diabet | DMSO

24.88

★★★★★4.8 (132)